Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yaqin Wu, Anpeng Wang, Biqing Zhu, Jian Huang, Emei Lu, Hanzi Xu, Wenjie Xia, Gaochao Dong, Feng Jiang & Lin Xu. (2018) KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer. OncoTargets and Therapy 11, pages 1707-1720.
Read now
Read now
Articles from other publishers (36)
Jiaojiao Zheng, Yuqin Tan, Xiaofeng Liu, Chunfeng Zhang, Kunqi Su, Yang Jiang, Jianyuan Luo, Li Li & Xiaojuan Du. (2022) NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation. Cell Death & Differentiation 29:4, pages 846-860.
Crossref
Crossref
William D.J. Tremlett, David M. Goodman, Tasha R. Steel, Saawan Kumar, Anna Wieczorek-Błauż, Fearghal P. Walsh, Matthew P. Sullivan, Muhammad Hanif & Christian G. Hartinger. (2021) Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands. Coordination Chemistry Reviews 445, pages 213950.
Crossref
Crossref
Yu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, Yao-Ming Wu, Chiun Hsu, Chih-Hung Hsu, Hey-Chi Hsu, Ann-Lii Cheng & Zhong-Zhe Lin. (2021) Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma. Cells 10:7, pages 1698.
Crossref
Crossref
Zemene Demelash Kifle, Meklit Tadele, Eyerusalem Alemu, Tadele Gedamu & Akeberegn Gorems Ayele. (2021) A recent development of new therapeutic agents and novel drug targets for cancer treatment. SAGE Open Medicine 9, pages 205031212110670.
Crossref
Crossref
Victoria C. Yan, Hannah E. Butterfield, Anton H. Poral, Matthew J. Yan, Kristine L. Yang, Cong-Dat Pham & Florian L. Muller. (2020) Why Great Mitotic Inhibitors Make Poor Cancer Drugs. Trends in Cancer 6:11, pages 924-941.
Crossref
Crossref
Michał Łomzik, Muhammad Hanif, Aleksandra Budniok, Andrzej Błauż, Anna Makal, Daniel M. Tchoń, Barbara Leśniewska, Kelvin K. H. Tong, Sanam Movassaghi, Tilo Söhnel, Stephen M. F. Jamieson, Ayesha Zafar, Jóhannes Reynisson, Błażej Rychlik, Christian G. Hartinger & Damian Plażuk. (2020) Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands. Inorganic Chemistry 59:20, pages 14879-14890.
Crossref
Crossref
Karin Hansson, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M. Smith, Kristian Pietras, Sven PåhlmanKrister Wennerberg, David GisselssonDaniel Bexell. (2020) Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science Translational Medicine 12:562.
Crossref
Crossref
Pilli Govindaiah, Naresh Dumala, Paramjit Grover & M. Jaya Prakash. (2019) Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents. Bioorganic & Medicinal Chemistry Letters 29:14, pages 1819-1824.
Crossref
Crossref
Helder Maiato, Ana Gomes, Filipe Sousa & Marin Barisic. (2017) Mechanisms of Chromosome Congression during Mitosis. Biology 6:4, pages 13.
Crossref
Crossref
Ece Bayir, Eyup Bilgi & Aylin Sendemir Urkmez. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
1212
1257
.
Mai Kasahara, Makoto Nagahara, Tsuyoshi Nakagawa, Toshiaki Ishikawa, Takanobu Sato, Hiroyuki Uetake & Kenichi Sugihara. (2016) Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer. Oncology Letters 12:3, pages 1909-1914.
Crossref
Crossref
Patricia M. LoRusso, Priscila H. Goncalves, Lindsay Casetta, Judith A. Carter, Kevin Litwiler, Dale Roseberry, Selena Rush, Jennifer Schreiber, Heidi M. Simmons, Mieke Ptaszynski & Edward A. Sausville. (2015) First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors. Investigational New Drugs 33:2, pages 440-449.
Crossref
Crossref
Ece Bayir, Eyup Bilgi & Aylin Sendemir Urkmez. 2014. Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials. Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials
447
491
.
Sandra Craig, Lei Gao, Irene Lee, Thomas Gray & Anthony J. Berdis. (2012) Gold-Containing Indoles as Anticancer Agents That Potentiate the Cytotoxic Effects of Ionizing Radiation. Journal of Medicinal Chemistry 55:5, pages 2437-2451.
Crossref
Crossref
Vincent Chung, Elisabeth I. Heath, William R. Schelman, Brendan M. Johnson, Lyndon C. Kirby, Kerlin M. Lynch, Jeffrey D. Botbyl, Thomas A. Lampkin & Kyle D. Holen. (2011) First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemotherapy and Pharmacology 69:3, pages 733-741.
Crossref
Crossref
Lei Jiang, Yiu-Kay Lai, Jinfang Zhang, Hua Wang, Marie C M Lin, Ming-liang He & Hsiang-fu Kung. (2011) Targeting S100P Inhibits Colon Cancer Growth and Metastasis by Lentivirus-Mediated RNA Interference and Proteomic Analysis. Molecular Medicine 17:7-8, pages 709-716.
Crossref
Crossref
Howard A. BurrisIIIIII, Suzanne F. Jones, Daphne D. Williams, Steven J. Kathman, Jeffrey P. Hodge, Lini Pandite, Peter T. C. Ho, Scott A. Boerner & Patricia LoRusso. (2010) A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors. Investigational New Drugs 29:3, pages 467-472.
Crossref
Crossref
Mi-Kyung Hwang, Yong-Ki Min & Seong-Hwan Kim. (2011) Kinesin Spindle Protein Inhibitor HR22C16 Sensitizes TRAIL-induced Apoptosis in Human Lung Cancer H1299 Cells. Bulletin of the Korean Chemical Society 32:5, pages 1737-1740.
Crossref
Crossref
Sandra Ackermann, Felix Goeser, Johannes H. Schulte, Alexander Schramm, Volker Ehemann, Barbara Hero, Angelika Eggert, Frank Berthold & Matthias Fischer. (2011) Polo-Like Kinase 1 is a Therapeutic Target in High-Risk Neuroblastoma. Clinical Cancer Research 17:4, pages 731-741.
Crossref
Crossref
Anindra Sharma, Bandana Chakravarti, Munna Prasad Gupt, Jawed A. Siddiqui, Rituraj Konwar & Rama P. Tripathi. (2010) Synthesis and anti breast cancer activity of biphenyl based chalcones. Bioorganic & Medicinal Chemistry 18:13, pages 4711-4720.
Crossref
Crossref
Balasubramanian Srinivasan, Thomas E. Johnson, Rahul Lad & Chengguo Xing. (2009) Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities. Journal of Medicinal Chemistry 52:22, pages 7228-7235.
Crossref
Crossref
Christopher F. Claiborne & Mark G. Manfredi. 2009. Kinase Inhibitor Drugs. Kinase Inhibitor Drugs
333
350
.
B Z Carter, D H Mak, R Woessner, S Gross, W D Schober, Z Estrov, H Kantarjian & M Andreeff. (2009) Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells. Leukemia 23:10, pages 1755-1762.
Crossref
Crossref
Zong-Ying Liu, Yue-Ming Wang, Zhuo-Rong Li, Jian-Dong Jiang & David W. Boykin. (2009) Synthesis and anticancer activity of novel 3,4-diarylthiazol-2(3H)-ones (imines). Bioorganic & Medicinal Chemistry Letters 19:19, pages 5661-5664.
Crossref
Crossref
Su-Nam Kim, Nam Hyun Kim, Yeon Sook Park, Hanna Kim, Seokjoon Lee, Qian Wang & Yong Kee Kim. (2009) 7-Diethylamino-3(2′-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells. Biochemical Pharmacology 77:12, pages 1773-1779.
Crossref
Crossref
Meredith C. Henderson, Yeng-Jeng Y. Shaw, Hong Wang, Haiyong Han, Laurence H. Hurley, Gary Flynn, Robert T. Dorr & Daniel D. Von Hoff. (2009) UA62784, a novel inhibitor of centromere protein E kinesin-like protein. Molecular Cancer Therapeutics 8:1, pages 36-44.
Crossref
Crossref
Christopher D. Cox, Paul J. Coleman, Michael J. Breslin, David B. Whitman, Robert M. Garbaccio, Mark E. Fraley, Carolyn A. Buser, Eileen S. Walsh, Kelly Hamilton, Michael D. Schaber, Robert B. Lobell, Weikang Tao, Joseph P. Davide, Ronald E. Diehl, Marc T. Abrams, Vicki J. South, Hans E. Huber, Maricel Torrent, Thomayant Prueksaritanont, Chunze Li, Donald E. Slaughter, Elizabeth Mahan, Carmen Fernandez-Metzler, Youwei Yan, Lawrence C. Kuo, Nancy E. Kohl & George D. Hartman. (2008)
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2
S
)-4-(2,5-Difluorophenyl)-
N
-[(3
R
,4
S
)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-
N
-methyl-2-phenyl-2,5-dihydro-1
H
-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
. Journal of Medicinal Chemistry 51:14, pages 4239-4252.
Crossref
Crossref
Lusong Luo, Jeffrey D. Carson, Kathleen S. Molnar, Steven J. Tuske, Stephen J. Coales, Yoshitomo Hamuro, Chiu-mei Sung, Valery Sudakin, Kurt R. Auger, Dashyant Dhanak, Jeffrey R. Jackson, Pearl S. Huang, Peter J. Tummino & Robert A. Copeland. (2008) Conformation-Dependent Ligand Regulation of ATP Hydrolysis by Human KSP: Activation of Basal Hydrolysis and Inhibition of Microtubule-Stimulated Hydrolysis by a Single, Small Molecule Modulator. Journal of the American Chemical Society 130:24, pages 7584-7591.
Crossref
Crossref
Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Christian Chabannon, Colette Charpin, Max Chaffanet, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum & François Bertucci. (2008) Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis. Cancer Research 68:3, pages 767-776.
Crossref
Crossref
Joana Marinho, Madalena Pedro, Diana C.G.A. Pinto, Artur M.S. Silva, José A.S. Cavaleiro, Claudio E. Sunkel & Maria São José Nascimento. (2008) 4′-Methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent. Biochemical Pharmacology 75:4, pages 826-835.
Crossref
Crossref
J. Robert. (2007) Les poisons du fuseauSpindle poisons. Oncologie 9:11, pages 766-772.
Crossref
Crossref
Paul J. Coleman, John D. Schreier, Christopher D. Cox, Mark E. Fraley, Robert M. Garbaccio, Carolyn A. Buser, Eileen S. Walsh, Kelly Hamilton, Robert B. Lobell, Keith Rickert, Weikang Tao, Ronald E. Diehl, Vicki J. South, Joseph P. Davide, Nancy E. Kohl, Youwei Yan, Lawrence Kuo, Thomayant Prueksaritanont, Chunze Li, Elizabeth A. Mahan, Carmen Fernandez-Metzler, Joseph J. Salata & George D. Hartman. (2007) Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP. Bioorganic & Medicinal Chemistry Letters 17:19, pages 5390-5395.
Crossref
Crossref
John B. Hijjawi & David G. Dennison. (2007) Acute Felon as a Complication of Systemic Paclitaxel Therapy: Case Report and Review of the Literature. HAND 2:3, pages 101-103.
Crossref
Crossref
Penelope R. Chua, David M. Roof, Yan Lee, Roman Sakowicz, David Clarke, Dan Pierce, Thoryn Stephens, Matthew Hamilton, Brad Morgan, David Morgans, Takashi Nakai, Adam Tomasi & Mary E. Maxon. (2007) Effective killing of the human pathogen Candida albicans by a specific inhibitor of non-essential mitotic kinesin Kip1p. Molecular Microbiology 65:2, pages 347-362.
Crossref
Crossref
Shailaja Kasibhatla, Vijay Baichwal, Sui Xiong Cai, Bruce Roth, Ira Skvortsova, Sergej Skvortsov, Peter Lukas, Nicole M. English, Nilantha Sirisoma, John Drewe, Azra Pervin, Ben Tseng, Robert O. Carlson & Christopher M. Pleiman. (2007) MPC-6827: A Small-Molecule Inhibitor of Microtubule Formation That Is Not a Substrate for Multidrug Resistance Pumps. Cancer Research 67:12, pages 5865-5871.
Crossref
Crossref
Christopher D. Cox, Michael J. Breslin, David B. Whitman, Paul J. Coleman, Robert M. Garbaccio, Mark E. Fraley, Matthew M. Zrada, Carolyn A. Buser, Eileen S. Walsh, Kelly Hamilton, Robert B. Lobell, Weikang Tao, Marc T. Abrams, Vicki J. South, Hans E. Huber, Nancy E. Kohl & George D. Hartman. (2007) Kinesin spindle protein (KSP) inhibitors. Part V: Discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by β-fluorination to overcome cellular efflux by P-glycoprotein. Bioorganic & Medicinal Chemistry Letters 17:10, pages 2697-2702.
Crossref
Crossref